BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1127824)

  • 1. Study of an intravenous fat tolerance test with Intralipid. II. The relation between K2 and PHLA with special reference to clinical data in human subjects.
    Wada K; Murakami K; Sakaguchi R; Mise J
    Jpn Circ J; 1975 Jan; 39(1):1-5. PubMed ID: 1127824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further methodological studies on the intravenous fat tolerance with Intralipid emulsion.
    Rössner S
    Scand J Clin Lab Invest; 1976 Mar; 36(2):155-9. PubMed ID: 1273493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between triglycerides in human skeletal muscle and serum and the fractional elimination rate of exogenous plasma triglycerides.
    Fröberg SO; Rössner S; Ericsson M
    Eur J Clin Invest; 1978 Apr; 8(2):93-7. PubMed ID: 417941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractional removal rate of fat emulsion (K2) remains to be low in APOE3/3 phenotype subjects with serum triglyceride level above 180mg/dl.
    Ikeuchi R; Sakuma N; Hayano J; Fujinami T
    Life Sci; 1998; 62(7):665-71. PubMed ID: 9472725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between fractional turnover rate of endogenous plasma triglycerides and of intralipid (intravenous fat tolerance test) in man.
    Rössner S; Boberg J; Carlson LA; Freyschuss U; Lassers BW
    Eur J Clin Invest; 1974 Apr; 4(2):109-14. PubMed ID: 4365001
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma triglyceride metabolism in thyroid disease.
    Nikkilä EA; Kekki M
    J Clin Invest; 1972 Aug; 51(8):2103-14. PubMed ID: 4341014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous fat tolerance. Correlation with very low density lipoprotein apoprotein B kinetics in man.
    Nicoll A; Sigurdsson G; Marsh A; Lewis B
    Atherosclerosis; 1977 Jan; 26(1):17-22. PubMed ID: 189778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal lipoprotein lipase in familial exogenous hypertriglyceridemia.
    Schreibman PH; Arons DL; Saudek CD; Arky RA
    J Clin Invest; 1973 Aug; 52(8):2075-82. PubMed ID: 4719678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible abnormalities in postheparin lipolytic activity during the late phase of release in diabetes mellitus (postheparin lipolytic activity in diabetes).
    Brunzell JD; Porte D; Bierman EL
    Metabolism; 1975 Oct; 24(10):1123-37. PubMed ID: 1165728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of lipid metabolic coefficient K2 in patients with hyperlipoproteinemia type IV before and after reduction of triglyceride level by adapted diet therapy].
    Drouin P; Lambert D; Mejean L; Pointel JP; Debry G
    Nutr Metab; 1979; 23(5):416-28. PubMed ID: 225702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperlipidaemia in untreated nephrotic syndrome, increased production or decreased removal?
    Chan MK; Persaud JW; Ramdial L; Varghese Z; Sweny P; Moorhead JF
    Clin Chim Acta; 1981 Dec; 117(3):317-23. PubMed ID: 7318185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein lipase, intravenous fat tolerance test, and the influence of fat-rich or carbohydrate-rich diet on plasma triglyceride levels in primary hyperglyceridemia.
    Cybulska B; Szostak WB
    Mater Med Pol; 1974; 6(3):169-77. PubMed ID: 4444332
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the intravenous fat tolerance test in chronic renal disease.
    Russell GI; Davies TG; Walls J
    Clin Nephrol; 1980 Jun; 13(6):282-6. PubMed ID: 7408247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipid composition of circulating lipoproteins in various types of hyperlipoproteinemia (author's transl)].
    Jaillard J; Sezille G; Dewailly P; Fruchart JC
    Diabete Metab; 1977 Sep; 3(3):159-64. PubMed ID: 199484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma lipid values and lipoprotein patterns during adolescence in boys.
    Court JM; Dunlop M
    J Pediatr; 1975 Mar; 86(3):453-8. PubMed ID: 163307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
    Hazzard WR; Goldstein JL; Schrott MG; Motulsky AG; Bierman EL
    J Clin Invest; 1973 Jul; 52(7):1569-77. PubMed ID: 4352458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous fat tolerance test with Intralipid in chronic renal failure.
    Norbeck HE; Rössner S
    Acta Med Scand; 1982; 211(1-2):69-74. PubMed ID: 7072523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipoprotein composition in different types of hyperlipoproteinemia.
    Carlson LA
    Adv Exp Med Biol; 1975; 63():185-99. PubMed ID: 173148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective deficiency of hepatic triglyceride lipase and hypertriglyceridaemia in kwashiorkor.
    Agbedana EO; Johnson AO; Taylor GO
    Br J Nutr; 1979 Nov; 42(3):351-6. PubMed ID: 228697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.